Delivery Order SPE2DB22D9251-SPE2DB25FR1JB
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $1,670.13 by the Defense Logistics Agency for the supply of YF-VAX 1 Dose Vials. This firm fixed-price delivery order, issued on July 24, 2025, carries an ultimate completion date of August 14, 2025, with no set-aside designation applied to the award. The contract represents a continuation of DMS Pharmaceutical Group's substantial role...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $27,835.50 by the Defense Logistics Agency for YF-VAX 1 dose vials. The contract is firm fixed price with no set-aside designation, reflecting the company's competitive standing in federal procurement. The delivery order is set for ultimate completion by August 15, 2025, with performance to take place at the vendor's Park Ridge, Illinois...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,783.55 by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order, with an ultimate completion date of October 1, 2025, carries no set-aside designation and represents a specific product requisition fulfilled under DMS Pharmaceutical Group's broader...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency valued at $11,134.20 for YF-VAX 1 dose vials. The award, issued on July 11, 2025, with an ultimate completion date of August 1, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on September 15, 2025, for YF-VAX 1 dose vials with a ceiling value of $2,226.84. This firm fixed-price delivery order, with an ultimate completion date of October 6, 2025, represents a routine pharmaceutical supply fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,134.20 by the Defense Logistics Agency on April 23, 2025, for the delivery of YF-VAX 1 dose vials. The contract contains no set-aside designation and is scheduled for completion by May 14, 2025, with performance taking place in Park Ridge, Illinois. This delivery order falls under DMS Pharmaceutical Group's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $54,730.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of YF-VAX 1 dose vials, with a performance period ending on June 9, 2023. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the YF-VAX 1 dose vaccine vials and has a completion date of November 30, 2021. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,567.10 by the Defense Logistics Agency (DLA) on July 10, 2025, for the supply of YF-VAX 1 dose vials. The contract carries a firm fixed-price structure with an ultimate completion date of July 31, 2025, and was awarded without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 25, 2025, for YF-VAX 1 dose vials with a ceiling value of $2,226.84. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 15, 2025, and will be performed at the vendor's Park Ridge location. The award falls under DMS Pharmaceutical...
- SPE2DB22D9251Indefinite Delivery Contract
- SPE2DB22D9251-SPE2DB25FR1JBDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on July 11, 2025, for YF-VAX 1 dose vials valued at $8,350.65. This firm fixed-price delivery order, which carries no set-aside designation, is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499.9 million and valid through November 2026. The contract ultimate completion date is August 1, 2025, with the place of performance in Park Ridge, Illinois. The delivery order represents DMS Pharmaceutical Group's ongoing role as a critical supplier within the federal pharmaceutical supply chain, specifically supporting the Department of Defense healthcare systems. The company's core business involves distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to military and federal healthcare facilities nationwide. This award exemplifies the company's consistent positioning as a preferred vendor for the DLA's pharmaceutical procurement needs, leveraging its woman-owned small business status to compete effectively in federal markets while providing essential medical supplies to defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 7/11/25 |